| Wolfeboro Bay Center | |
| 39 Clipper Drive, Wolfeboro, New Hampshire 03894 | |
| (603) 569-3950 | |
| Name | Wolfeboro Bay Center |
|---|---|
| Location | 39 Clipper Drive, Wolfeboro, New Hampshire |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 104 |
| Occupancy Rate | 78.94% |
| Medicare ID (CCN) | 305083 |
| Legal Business Name | Sunbridge Clipper Home Of Wolfeboro Llc |
| Ownership Type | For Profit - Corporation |
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Biomedical researchers at the University of Arkansas in Fayetteville and the University of Arkansas for Medical Sciences (UAMS) in Little Rock have developed a special contrast-imaging agent made of gold-coated carbon nanotubes that is capable of molecular mapping of lymphatic endothelial cells and detecting cancer metastasis in sentinel lymph nodes.
Anadys Pharmaceuticals, Inc. today announced preliminary results from a planned interim analysis of data at four weeks for the first dose cohort, 200 mg bid, in an ongoing Phase II study of ANA598 in combination with pegylated interferon and ribavirin (SOC) in HCV patients.
The Sohn Conference Foundation today announced a $50,000 grant to support funding of a Phase 2 cutting-edge pediatric clinical trial from the Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC) now extending to New York City.
A study conducted by researchers in Finland suggests that children who are exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in schools are unlikely to transmit the virus further and play any significant role in the spread of coronavirus disease 2019 (COVID-19).
Children whose parents and families are under ongoing stress have more fevers with illness than other children. Published this month in the Archives of Pediatric and Adolescent Medicine, the study also shows the unanticipated conclusion that children's natural killer cell function, part of the body's innate immune system, increases under chronic stress, unlike adults, whose function is decreased.
› Verified 6 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 18.92 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 4.57 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 31.71 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.08 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 3.74 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 3.44 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 4.68 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 25.36 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 97.2 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.5 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 36.41 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 9.38 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 5.35 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 95.47 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 74.29 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 63.44 | 82.93 |
News Archive
Biomedical researchers at the University of Arkansas in Fayetteville and the University of Arkansas for Medical Sciences (UAMS) in Little Rock have developed a special contrast-imaging agent made of gold-coated carbon nanotubes that is capable of molecular mapping of lymphatic endothelial cells and detecting cancer metastasis in sentinel lymph nodes.
Anadys Pharmaceuticals, Inc. today announced preliminary results from a planned interim analysis of data at four weeks for the first dose cohort, 200 mg bid, in an ongoing Phase II study of ANA598 in combination with pegylated interferon and ribavirin (SOC) in HCV patients.
The Sohn Conference Foundation today announced a $50,000 grant to support funding of a Phase 2 cutting-edge pediatric clinical trial from the Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC) now extending to New York City.
A study conducted by researchers in Finland suggests that children who are exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in schools are unlikely to transmit the virus further and play any significant role in the spread of coronavirus disease 2019 (COVID-19).
Children whose parents and families are under ongoing stress have more fevers with illness than other children. Published this month in the Archives of Pediatric and Adolescent Medicine, the study also shows the unanticipated conclusion that children's natural killer cell function, part of the body's innate immune system, increases under chronic stress, unlike adults, whose function is decreased.
› Verified 6 days ago